The atom is the new microchip. Our increasing ability to understand and engineer biology using tools such as CRISPR is opening up new possibilities.

The future of health is here.

After decades of fundamental research and technological advancement, scientists can better understand the human genome, identify disease earlier, map its progression, and proactively intervene to help people more effectively sustain their health.

It’s a profound leap in capability which allows us to cure – not just treat – previously incurable diseases by editing an individual’s genome, produce meat without animals, and manufacture new industrial chemicals to spur a new industrial revolution.

Rapid and ever-cheaper DNA sequencing has deepened our understanding of how biology fundamentally works and tools such as CRISPR genome engineering are now being used in labs around the world to reimagine and scale what were once artisanal processes.

This revolutionary capability of rewriting biology are providing with new tools and strategies to help tackle our most intractable health and climate challenges. This is science – not science fiction – and these advancements are rapidly moving from the lab to the clinic and field.

The Biorevolution is already benefiting our society in tangible and profound ways. For example, a combination of biological breakthroughs and ever faster and more sophisticated computing, data analytics, and artificial intelligence technologies has powered scientific responses to the Covid-19 pandemic.

Using new approaches, scientists sequenced the virus’ genome in weeks rather than months, which enabled a deep investigation of the transmission patterns of the virus, the search for effective therapies, the development of mRNA vaccines, and the rapid introduction of clinical trials of vaccines – all in record-breaking time which no doubt saved countless lives.

As we push forward into this new era for medicine, agriculture, and climate change mitigation, the ethical questions continue to be debated. The goal must be for technologies such as CRISPR to be responsibly applied and benefit the most number of people with the greatest need.

This is the ongoing basis of our work with Nobel Laureate and CRISPR pioneer Dr. Jennifer Doudna and a core reason why Thermal continues to be the world’s leading PR agency for companies pushing the Biorevolution forward.


“The concern that occupies my mind the most right now is affordability and accessibility of genome-editing technology. We’re approaching a time when we will have the ability to use CRISPR to cure genetic diseases, but the question becomes ‘For whom?””

Dr. Jennifer Doudna, Nobel Laureate and co-inventor of CRISPR technology


Read about some of the work we are doing with our Biorevolution clients here and a selection of the high impact media coverage we have secured here.


This is a unique website which will require a more modern browser to work!

Please upgrade today!